Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia.

Growth Factors
Karin LarssonTorbjörn Karlsson

Abstract

Individuals suffering from cancer, including hematological malignancies, are at increased risk of cardiovascular disease (CVD). Elevated levels of several biomarkers in blood are associated with an increased risk of CVD. The aim of this study was to investigate whether a subset of such CVD risk biomarkers was elevated in patients with untreated chronic lymphocytic leukemia (CLL). Blood plasma and serum from 139 CLL patients and 71 healthy age-matched controls were analyzed for 11 proposed CVD risk biomarkers. The CLL cohort displayed a more heterogeneous pattern of biomarker expression compared to controls. The majority, eight out of 11, analyzed CVD risk biomarkers differed significantly in concentrations between CLL patients and controls. Increased levels of the biomarkers GDF15 and myostatin have not previously been reported in CLL. Further prospective studies are warranted to investigate whether these biomarkers predict future cardiovascular events in patients with CLL.

References

Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·M R BootcovS N Breit
Apr 3, 2004·British Journal of Haematology·Aura S KamigutiJohn C Cawley
Jun 27, 2008·European Journal of Clinical Investigation·P CostelliF Rossi Fanelli
Dec 9, 2009·Annual Review of Immunology·Barbara BottazziAlberto Mantovani
Oct 27, 2011·Journal of Internal Medicine·R A de BoerP van der Harst
Jun 4, 2013·Journal of the American College of Cardiology·Omair YousufMatthew J Budoff
Aug 15, 2013·Critical Reviews in Oncology/hematology·Uri RozovskiZeev Estrov
Jan 8, 2017·Clinical Chemistry·Kai C WollertLars Wallentin
Mar 3, 2017·BMC Cardiovascular Disorders·Ling YouWei Cui
Jun 22, 2017·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Jan 20, 2018·Journal of Cardiovascular Translational Research·Laura LahdentaustaPirkko J Pussinen
Apr 26, 2019·Frontiers in Immunology·Andrea DoniBarbara Bottazzi
May 6, 2019·European Journal of Internal Medicine·Pingan ChenDingli Xu
Oct 6, 2019·Biochemical and Biophysical Research Communications·Noemí Aguilera-MontillaAngeles García-Pardo
Jan 10, 2020·Journal of Clinical Laboratory Analysis·Mengqi GongTong Liu
Feb 9, 2020·Journal of the American Society of Nephrology : JASN·Jing LiuAndrew P McMahon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.